Results 261 to 270 of about 260,495 (313)
Experience with the mobile health application 'mSaada' to facilitate home-based human papillomavirus testing in Western Kenya. [PDF]
Nguyen NTT +8 more
europepmc +1 more source
Classification of Platelet‐Activating Anti‐Platelet Factor 4 Disorders
ABSTRACT Introduction The prototypic anti‐platelet factor 4 (PF4) disorder—heparin‐induced thrombocytopenia and thrombosis (HITT)—features immunoglobulin G (IgG) class antibodies that activate platelets, monocytes, and neutrophils in a mainly heparin‐dependent fashion via Fcγ receptor‐dependent cellular activation.
Theodore E. Warkentin
wiley +1 more source
Human papillomavirus vaccination: if the vaccine is important and available, why not use it? [PDF]
Freire GS +9 more
europepmc +1 more source
HIV: is it now a thing of the past?
Abstract Effective antiviral therapy for human immunodeficiency virus (HIV) has substantially reduced HIV‐associated morbidity and mortality for people living with HIV (PLWH). The use of antiviral therapies as prevention, most notably pre‐exposure prophylaxis (PrEP) as well as treatment as prevention (TasP), has significantly reduced the number of new ...
Jeffrey John Post
wiley +1 more source
Correction: A scoping review of human papillomavirus related data system in China. [PDF]
Li Y +6 more
europepmc +1 more source
Multiprofessional Family Care for Women With Gynaecological Cancer
ABSTRACT Aim The aim of this study was to determine how family care is implemented in the care of women with gynaecological cancer from the perspective of health professionals in Finland. Design Multiphase convergent mixed‐methods research. Methods This study is based on two datasets collected from one Finnish university hospital. The first dataset was
Tea Metsävainio +4 more
wiley +1 more source
Advances in understanding the mechanisms of the human papillomavirus oncoproteins. [PDF]
Obanya DI, Wootton LM, Morgan EL.
europepmc +1 more source
ABSTRACT Background Research indicates various barriers to cervical cancer screening for transgender people, contributing to cancer inequities. Further research is required to better understand how these barriers affect experiences along the screening trajectory, from engaging with information, through invitation and testing, to receiving test results.
Max Kleijberg, Lars E. Eriksson
wiley +1 more source

